In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA1c lowering is associated with haematological changes. (2021)

First Author: N'Dow SMS
Attributed to:  Investigation of the target of metformin funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dme.14463

PubMed Identifier: 33236391

Publication URI: http://europepmc.org/abstract/MED/33236391

Type: Journal Article/Review

Volume: 38

Parent Publication: Diabetic medicine : a journal of the British Diabetic Association

Issue: 9

ISSN: 0742-3071